GlassScriptPrepare for your visit
Jason A Rothbart
Obstetrics & Gynecology · Los Angeles, CA · NPI 1316944200
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,113.33
in general payments reported to CMS, 2019-2025 · $372 in 2025
The $372 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $509.09
- Mayne Pharma Commercial LLC $468.28
- Exeltis, USA INC. $151.50
- Coopersurgical, INC. $136.72
- Astellas Pharma US INC $134.40
- Therapeuticsmd, INC. $128.30
Drugs and devices associated with these payments
Veozah Slynd Zurzuvae Ova1 Twirla Femlyv Genexpert Vivjoa Lo Loestrin Fe Accrufer Estrogel Myfembree
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jason Rothbart listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/14647/jason-a-rothbart